352 related articles for article (PubMed ID: 31906317)
1. Reduced Levels of Cerebrospinal Fluid/Plasma Aβ40 as an Early Biomarker for Cerebral Amyloid Angiopathy in RTg-DI Rats.
Zhu X; Xu F; Hoos MD; Lee H; Benveniste H; Nostrand WEV
Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31906317
[TBL] [Abstract][Full Text] [Related]
2. A Novel Transgenic Rat Model of Robust Cerebral Microvascular Amyloid with Prominent Vasculopathy.
Davis J; Xu F; Hatfield J; Lee H; Hoos MD; Popescu D; Crooks E; Kim R; Smith SO; Robinson JK; Benveniste H; Van Nostrand WE
Am J Pathol; 2018 Dec; 188(12):2877-2889. PubMed ID: 30446159
[TBL] [Abstract][Full Text] [Related]
3. Robust neuroinflammation and perivascular pathology in rTg-DI rats, a novel model of microvascular cerebral amyloid angiopathy.
Zhu X; Hatfield J; Sullivan JK; Xu F; Van Nostrand WE
J Neuroinflammation; 2020 Mar; 17(1):78. PubMed ID: 32127016
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal Fluid Biomarkers and Amyloid-β Elimination from the Brain in Cerebral Amyloid Angiopathy-Related Inflammation.
Sakai K; Noguchi-Shinohara M; Tanaka H; Ikeda T; Hamaguchi T; Kakita A; Yamada M; Ono K
J Alzheimers Dis; 2023; 91(3):1173-1183. PubMed ID: 36565118
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal Cognitive Decline in a Novel Rodent Model of Cerebral Amyloid Angiopathy Type-1.
Popescu DL; Van Nostrand WE; Robinson JK
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32231123
[TBL] [Abstract][Full Text] [Related]
6. Early Aβ reduction prevents progression of cerebral amyloid angiopathy.
Schelle J; Wegenast-Braun BM; Fritschi SK; Kaeser SA; Jährling N; Eicke D; Skodras A; Beschorner N; Obermueller U; Häsler LM; Wolfer DP; Mueggler T; Shimshek DR; Neumann U; Dodt HU; Staufenbiel M; Jucker M
Ann Neurol; 2019 Oct; 86(4):561-571. PubMed ID: 31359452
[TBL] [Abstract][Full Text] [Related]
7. Diffuse white matter loss in a transgenic rat model of cerebral amyloid angiopathy.
Lee H; Xu F; Liu X; Koundal S; Zhu X; Davis J; Yanez D; Schrader J; Stanisavljevic A; Rothman DL; Wardlaw J; Van Nostrand WE; Benveniste H
J Cereb Blood Flow Metab; 2021 May; 41(5):1103-1118. PubMed ID: 32791876
[TBL] [Abstract][Full Text] [Related]
8. Cerebral Amyloid Angiopathy-Related Microbleeds and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease.
Noguchi-Shinohara M; Komatsu J; Samuraki M; Matsunari I; Ikeda T; Sakai K; Hamaguchi T; Ono K; Nakamura H; Yamada M
J Alzheimers Dis; 2017; 55(3):905-913. PubMed ID: 27802236
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy.
Banerjee G; Ambler G; Keshavan A; Paterson RW; Foiani MS; Toombs J; Heslegrave A; Dickson JC; Fraioli F; Groves AM; Lunn MP; Fox NC; Zetterberg H; Schott JM; Werring DJ
J Alzheimers Dis; 2020; 74(4):1189-1201. PubMed ID: 32176643
[TBL] [Abstract][Full Text] [Related]
10. rTg-D: A novel transgenic rat model of cerebral amyloid angiopathy Type-2.
Davis J; Xu F; Zhu X; Van Nostrand WE
Cereb Circ Cogn Behav; 2022; 3():100133. PubMed ID: 36324401
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal Fluid Profile of Tau, Phosphorylated Tau, Aβ42, and Aβ40 in Probable Cerebral Amyloid Angiopathy.
Grangeon L; Paquet C; Guey S; Zarea A; Martinaud O; Rotharmel M; Maltête D; Quillard-Muraine M; Nicolas G; Charbonnier C; Chabriat H; Wallon D
J Alzheimers Dis; 2022; 87(2):791-802. PubMed ID: 35367960
[TBL] [Abstract][Full Text] [Related]
12. Core cerebrospinal fluid biomarker profile in cerebral amyloid angiopathy: A meta-analysis.
Charidimou A; Friedrich JO; Greenberg SM; Viswanathan A
Neurology; 2018 Feb; 90(9):e754-e762. PubMed ID: 29386280
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of urokinase plasminogen activator in rodent models and patients with cerebral amyloid angiopathy.
Vervuurt M; Zhu X; Schrader J; de Kort AM; Marques TM; Kersten I; Peters van Ton AM; Abdo WF; Schreuder FHBM; Rasing I; Terwindt GM; Wermer MJH; Greenberg SM; Klijn CJM; Kuiperij HB; Van Nostrand WE; Verbeek MM
Neuropathol Appl Neurobiol; 2022 Aug; 48(5):e12804. PubMed ID: 35266166
[TBL] [Abstract][Full Text] [Related]
14. Impact of Non-pharmacological Chronic Hypertension on a Transgenic Rat Model of Cerebral Amyloid Angiopathy.
Stanisavljevic A; Schrader JM; Zhu X; Mattar JM; Hanks A; Xu F; Majchrzak M; Robinson JK; Van Nostrand WE
Front Neurosci; 2022; 16():811371. PubMed ID: 35368255
[TBL] [Abstract][Full Text] [Related]
15. Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons.
Van Dorpe J; Smeijers L; Dewachter I; Nuyens D; Spittaels K; Van Den Haute C; Mercken M; Moechars D; Laenen I; Kuiperi C; Bruynseels K; Tesseur I; Loos R; Vanderstichele H; Checler F; Sciot R; Van Leuven F
Am J Pathol; 2000 Oct; 157(4):1283-98. PubMed ID: 11021833
[TBL] [Abstract][Full Text] [Related]
16. Decreased Cerebrospinal Fluid Amyloid β 38, 40, 42, and 43 Levels in Sporadic and Hereditary Cerebral Amyloid Angiopathy.
De Kort AM; Kuiperij HB; Marques TM; Jäkel L; van den Berg E; Kersten I; van Berckel-Smit HEP; Duering M; Stoops E; Abdo WF; Rasing I; Voigt S; Koemans EA; Kaushik K; Warren AD; Greenberg SM; Brinkmalm G; Terwindt GM; Wermer MJH; Schreuder FHBM; Klijn CJM; Verbeek MM
Ann Neurol; 2023 Jun; 93(6):1173-1186. PubMed ID: 36707720
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal Fluid, MRI, and Florbetaben-PET in Cerebral Amyloid Angiopathy-Related Inflammation.
Renard D; Collombier L; Demattei C; Wacongne A; Charif M; Ayrignac X; Azakri S; Gaillard N; Boudousq V; Lehmann S; Menjot de Champfleur N; Thouvenot E
J Alzheimers Dis; 2018; 61(3):1107-1117. PubMed ID: 29254099
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E markedly facilitates age-dependent cerebral amyloid angiopathy and spontaneous hemorrhage in amyloid precursor protein transgenic mice.
Fryer JD; Taylor JW; DeMattos RB; Bales KR; Paul SM; Parsadanian M; Holtzman DM
J Neurosci; 2003 Aug; 23(21):7889-96. PubMed ID: 12944519
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patients.
Vervuurt M; Schrader JM; de Kort AM; Kersten I; Wessels HJCT; Klijn CJM; Schreuder FHBM; Kuiperij HB; Gloerich J; Van Nostrand WE; Verbeek MM
Acta Neuropathol Commun; 2024 Jan; 12(1):6. PubMed ID: 38191511
[TBL] [Abstract][Full Text] [Related]
20. Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies.
Piazza F; Greenberg SM; Savoiardo M; Gardinetti M; Chiapparini L; Raicher I; Nitrini R; Sakaguchi H; Brioschi M; Billo G; Colombo A; Lanzani F; Piscosquito G; Carriero MR; Giaccone G; Tagliavini F; Ferrarese C; DiFrancesco JC
Ann Neurol; 2013 Apr; 73(4):449-58. PubMed ID: 23625526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
